Literature DB >> 11001193

Amiodarone optic neuropathy without disc edema.

M A Speicher1, M H Goldman, G A Chrousos.   

Abstract

A 48-year-old man presented with bilateral blurred vision and visual field changes while prescribed amiodarone. Improvement of vision and visual field defects was documented within 3 weeks after discontinuation of the medication, and complete resolution occurred at 3 months. A unique feature of this amiodarone-associated optic neuropathy is the absence of any optic nerve edema.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11001193     DOI: 10.1097/00041327-200020030-00007

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  5 in total

Review 1.  Amiodarone-associated optic neuropathy: a critical review.

Authors:  Rod S Passman; Charles L Bennett; Joseph M Purpura; Rashmi Kapur; Lenworth N Johnson; Dennis W Raisch; Dennis P West; Beatrice J Edwards; Steven M Belknap; Dustin B Liebling; Mathew J Fisher; Athena T Samaras; Lisa-Gaye A Jones; Katrina-Marie E Tulas; June M McKoy
Journal:  Am J Med       Date:  2012-03-03       Impact factor: 4.965

2.  Amiodarone-associated Optic Neuropathy-A Clinical Criteria-based Diagnosis?

Authors:  Katrin Fasler; Ghislaine L Traber; Gregor Peter Jaggi; Klara Landau
Journal:  Neuroophthalmology       Date:  2017-08-18

Review 3.  The clinical spectrum of amiodarone-associated optic neuropathy.

Authors:  Lenworth N Johnson; Gregory B Krohel; Eric R Thomas
Journal:  J Natl Med Assoc       Date:  2004-11       Impact factor: 1.798

4.  Absence of bilateral vision loss from amiodarone: a randomized trial.

Authors:  Joel S Mindel; Jill Anderson; Anne Hellkamp; George Johnson; Jeanne E Poole; Daniel B Mark; Kerry L Lee; Gust H Bardy
Journal:  Am Heart J       Date:  2007-05       Impact factor: 4.749

Review 5.  Clinical and Mechanistic Review of Amiodarone-Associated Optic Neuropathy.

Authors:  Reece Mitchell; Joseph Chacko
Journal:  Biomolecules       Date:  2022-09-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.